Physician profile
Christopher J Wolf
NPI 1942240833
$4,817.01
in general payments reported to CMS, 2019-2025
13 companies · $300 in 2025
The $300 reported for 2025 was more than what 77% of Sports Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,330 · 2020: $144 · 2021: $125 · 2022: $260 · 2023: $307 · 2024: $351 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,232.96 | 2019 | |
| Abbvie INC. | $990.13 | 2021-2025 | Botox, Qulipta, Ubrelvy |
| Elite Orthopedics, LLC | $134.66 | 2020-2023 | |
| Depuy Synthes Sales INC. | $96.03 | 2019-2024 | Monovisc |
| Allergan, INC. | $79.29 | 2019-2022 | |
| Pfizer INC. | $76.50 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $45.87 | 2022 | |
| Arteriocyte Medical Systems, INC. | $39.00 | 2021-2022 | |
| Lilly USA, LLC | $33.14 | 2021-2022 | |
| Amgen INC. | $32.57 | 2022 | |
| Antares Pharma, INC. | $30.28 | 2021 | |
| Fidia Pharma USA INC. | $13.84 | 2021 | |
| Ferring Pharmaceuticals INC. | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.